Cannabinoids, Learning, and Memory

Running, not enrolling · Phase 1 · Has a placebo group

Conditions studied: Cannabis, Psychotic Disorders

In brief

The overarching goal of this study is to characterize the effects of cannabinoids on working and episodic memory.

Key facts

Study ID

NCT02407808

Run by

Yale University

People needed

80

Starts

2015-02-01

Expected to finish

2027-12-01

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women aged 18 and 55 years (extremes included) on day of first dosing
• Exposed to cannabis at least once in their lifetime

You may not qualify if…

• Cannabis naive
• Positive pregnancy screen during screening
• Hearing deficits

Where it is running

• VA Connecticut Healthcare System — West Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.